login
login

Europe Daily Bulletin No. 13002

29 July 2022
Contents Publication in full By article 14 / 24
SECTORAL POLICIES / Health
European Commission secures up to 85 million doses of GSK’s Adjupanrix pandemic influenza vaccine
Brussels, 28/07/2022 (Agence Europe)

The European Commission announced on 28 July that the new Health Emergency Preparedness and Response Authority (HERA) had signed a Joint Procurement Agreement with the pharmaceutical company GSK for the purchase of Adjupanrix, a prototype fragmented virion, inactivated and adjuvanted vaccine, previously known as the ‘pandemic influenza vaccine’ (H5N1).

The vaccine is indicated for use in adults in the event of an influenza pandemic officially declared by the World Health Organization...

Contents

BEACONS
Russian invasion of Ukraine
ECONOMY - FINANCE - BUSINESS
SECTORAL POLICIES
EXTERNAL ACTION
NEWS BRIEFS